Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 190 of 5804
-
A smartphone camera may help emergency doctors spot severe breathing trouble — a trial puts it to the test
Disease control Not yet recruitingDyspnea is the subjective sensation of difficult or uncomfortable breathing. It accounts for approximately 10% of emergency department visits and 8% of calls to Emergency Medical Communication Centers. Nearly half of patients presenting with dyspnea require hospital admission, 15…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a common cholesterol drug slow batten disease?
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and efficacy of multiple doses of PLX-200 in patients with CLN3 disease.
Phase: PHASE3 • Sponsor: Polaryx Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could zapping kidney nerves tame stubborn high blood pressure and save hearts?
Disease control Not yet recruitingEMBRACE is a randomized, controlled, multicenter clinical study evaluating the effect of renal denervation on clinical adverse events in hypertensive patients undergoing staged percutaneous coronary intervention (PCI) for multivessel coronary artery disease.
Phase: NA • Sponsor: Ceric Sàrl • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could cord blood transfusions protect fragile preemies?
Disease control Not yet recruitingLong-term morbidities among very low birth weight infants remain a significant challenge. Oxidative stress is a key factor in the pathogenesis of 'free radical (FR) diseases of prematurity,' including retinopathy of prematurity, bronchopulmonary dysplasia, necrotizing enterocolit…
Phase: NA • Sponsor: University of Parma • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a diabetes drug tame the immune system in kidney disease?
Disease control Not yet recruitingWHY IS THIS RESEARCH BEING CONDUCTED? Membranous glomerulonephritis (MN) is an autoimmune disease that affects the kidneys through autoantibodies, meaning that antibodies produced by your body attack your own kidney cells. The appearance of these autoantibodies can be explained i…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a daily pill ease leg pain and swelling from vein disease?
Disease control Not yet recruitingThis multicenter, randomized, double-blind study is a phase III evaluates the safety and effectiveness of CLR prolonged-release tablets in patients with chronic venous insufficiency, has been shown to be effective in reducing the symptoms of itching, edema, spontaneous pain, and …
Phase: PHASE3 • Sponsor: Barbara Maglione • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could adding chemo to tarlatamab overcome resistance in lung cancer?
Disease control Not yet recruitingThe integration of tarlatamab, a bispecific T-cell engager molecule targeting both DLL3 and CD3, into the treatment algorithm for SCLC will substantially improve the prognosis of patients. Nevertheless, disease progression will inevitably occur. Major challenges for further impr…
Phase: PHASE2 • Sponsor: University of Cologne • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a talk therapy that boosts Self-Understanding prevent suicide?
Disease control Not yet recruitingThis study aims to validate MBT as an effective and viable intervention for implementation in public health services, with the potential to directly impact suicide prevention policies in the region.
Phase: NA • Sponsor: Fundación Judío Panameña (JUPA) • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New radiation trick may spare rectal cancer patients from surgery
Disease control Recruiting nowRectal cancer patients who do not achieve a complete response to standard of care chemotherapy and radiation often require surgical resection as part of curative intent therapy. This study will evaluate whether additional "focal" radiation delivered internally (rectal brachythera…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for frail cancer patients: enhertu trial targets Tough-to-Treat stomach and esophageal tumors
Disease control Not yet recruitingPurpose: This clinical trial is designed to evaluate the safety and effectiveness of Trastuzumab Deruxtecan for patients with HER2 Positive Newly Diagnosed Metastatic Esophageal, Gastric, GEJ Cancer. The goal is to determine how well this treatment works and to identify any poten…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for newborns: simpler syphilis treatment on trial
Disease control Not yet recruitingThe Investigator hypothesize that the treatment efficacy will be similar in both study arms. Secondary outcomes and endpoints will characterize safety by comparing adverse events (AEs), tolerability, and adherence to therapy in each arm. This is a Phase 4, open-label, multicente…
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill aims to cut lung infections in bronchiectasis patients
Disease control Not yet recruitingThis study aims to find out whether the tablet CHF10196 is safe and effective for people with non-cystic fibrosis bronchiectasis, a long-term lung disease that causes widened airways, mucus buildup, infections, and flare ups of symptoms. The main goal is to see whether CHF10196 c…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can Exercise-Powered immune cells stop leukemia from coming back?
Disease control Not yet recruitingThe primary objective of this proposal is to conduct the first-in-human randomized clinical trial evaluating prophylactic DLI-X (pro-DLI-X) for relapse prevention following matched sibling donor (MSD) or haploidentical (haplo) hematopoietic cell transplantation (HCT) in patients …
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New triple combo targets tough lung cancer liver spread
Disease control Not yet recruitingThis is clinical trial evaluating the safety and efficacy of radiotherapy combined with immunotherapy and chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC) and liver metastases.
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a Gut-Focused drug revive immunotherapy for tough melanomas?
Disease control Not yet recruitingThis first-in-human study will evaluate the safety, clinical activity, and immunologic effects of combining axelopran with nivolumab in patients with PD-1-refractory unresectable or metastatic cutaneous melanoma. Exploratory analyses incorporating opioid exposure history and post…
Phase: PHASE1, PHASE2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Experimental drug aims to improve breathing in lung sarcoidosis
Disease control Not yet recruitingA study of XTMAB-16 in patients with pulmonary sarcoidosis
Phase: PHASE1, PHASE2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Gut bacteria capsules may stop liver-related brain fog in veterans
Prevention Not yet recruitingThe goal of this clinical trial is to find out whether changing the microbes in the bowels of Veterans with cirrhosis and hepatic encephalopathy (a condition that affects the brain as a result of liver problems) using capsules made from microbes from healthy people can prevent fu…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Could a new oral ketamine capsule ease bipolar depression when other treatments fail?
Symptom relief Not yet recruitingThis study is testing a new oral ketamine treatment called KET-AD in adults with treatment-resistant bipolar depression (TRBD). The study will look at how safe and tolerable the treatment is, and whether it may help improve symptoms of depression when used together with a partici…
Phase: PHASE2 • Sponsor: Neurocentrx Pharma Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New drug could unblock Crohn's-Related bowel narrowing without surgery
Disease control Not yet recruitingMany patients with Crohn's disease (CD) develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramping, or vomiting after meals. Because of these symptoms, patients often require bowel resection surgery. The objective of this…
Phase: PHASE2 • Sponsor: Agomab Spain S.L.U. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Supercharged immune cells take on deadly brain tumors
Disease control Not yet recruitingTo find the best method of administering NK cells in patients with recurrent glioblastoma.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC